Who owns PETROS PHARMACEUTICALS INC?
- Ticker: PTPI
- CUSIP Number: 71678j209
Tip: Access positions for across all investors
Analyze quarterly positions in Petros Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Petros Pharmaceuticals stock
Who bought or sold PETROS PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 32k | $47k | 0% | Mar 2024 |
|
| BlackRock | 17k | $24k | 0% | Mar 2024 |
|
| Geode Capital Management | 11k | $16k | 0% | Mar 2024 |
|
| Tower Research Capital | 3.4k | $5.0k | 34% | Mar 2024 |
|
| Emfo | 1.0k | $1.5k | 0% | Mar 2024 |
|
| Morgan Stanley | 509.00 | $748.535400 | 2579% | Mar 2024 |
|
| Newbridge Financial Services Group | 120.00 | $177.996000 | 0% | Mar 2024 |
|
| Group One Trading | 79.00 | $116.999000 | 0% | Mar 2024 |
|
| Advisor Group Holdings | 14.00 | $21.000000 | 0% | Mar 2024 |
|
| Wells Fargo & Company | 12.00 | $18.000000 | 0% | Mar 2024 |
|
| Bank of America Corporation | 1.00 | $1.000000 | 0% | Mar 2024 |
|
Who sold out of Petros Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Virtu Financial | Dec 2023 | 25k | $35k |
| Schonfeld Strategic Advisors | Dec 2023 | 23k | $32k |
| First Manhattan | Sep 2023 | 10.00 | $17.000000 |